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1. Introduction 
Diabetes insipidus (DI) is a clinical condition characterized by excretion of large volume of 
low specific gravity urine (1). Diabetes insipidus can be central in which there is deficient 
production of arginine vasopressin (AVP) also known as anti-diuretric hormone (ADH) or 
nephrogenic in which there is end organ resistance to ADH action (1).   
2. Classification 
Etiological classification of diabetes insipidus is as follows. 
1. Central Diabetes Insipidus (CDI) 
A. Idiopathic  
B. Familial 
C. Structural Causes  
i. Congenital: Septo-optic dysplasia 
  Tuber cinereum Hamartoma 
ii. Traumatic: Iatrogenic, head trauma  
iii. Inflammatory: Tuberculous Meningitis 
 Sarcoidosis   
 Wegener’s granulomatosis 
 Lymphocytic Hypophysitis 
iv. Neoplastic:  
a. Pediatric:  
 Hypothalamic glioma 
 Craniopharyngioma 
 Intracranial Germ Cell Tumors 
 Teratoma 
 Langerhans Histiocytosis 
b. Adult: Metastasis 
2. Psychogenic: Compulsive intake of large amounts of fluid leading to inhibition of 
normal vasopressin (2). 
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3. Nephrogenic Diabetes Insipidus (NDI) 
A. Primary 
B. Secondary: Polycystic kidney disease, drug toxicity such as Lithium toxicity, analgesic 
nephropathy, reflux nephropathy, amyloidosis, acute tubular nephropathy (1) 
3. Etiopathogenesis 
Central diabetes insipidus is characterized by decreased secretion of ADH that results in 
polyuria and polydipsia by diminishing the patient’s ability to concentrate urine. Diminished 
or absent ADH can be the result of a defect in one or more sites involving the hypothalamic 
osmoreceptors, supraoptic or paraventricular nuclei, or the supraopticohypophyseal tract. In 
contrast, lesions of the posterior pituitary rarely cause permanent diabetes insipidus, because 
the ADH is produced in the hypothalamus and still can be secreted into the circulation (1, 3).  
Psychogenic diabetes insipidus is caused by compulsive intake of large amounts of fluid 
leading to inhibition of normal vasopressin (2). 
Nephrogenic diabetes insipidus is characterized by a decrease in the ability to concentrate 
the urine due to resistance to ADH action in the kidney. NDI can be observed chronic renal 
insufficiency, Lithium toxicity, Hypocalcaemia and tubular interstitial disease (1, 4, 5). 
4. Relevant anatomy 
Sella turcica is a saddle shaped fossa located in the sphenoid bone. It is bounded by the 
prechiasmal sulcus, tuberculum sella and by the anterior clinoid processes. Sphenoid sinus 
lies below and anterior to it. The bony margins of sella are best seen with computed 
tomography (CT scan). The fatty bone marrow of the bones of the sella creates hyperintense 
T1 signal on magenetic resonance imaging (MRI). Suprasellar cistern is a CSF space located 
just above the sella and contains vessels forming the circle of Willis. Optic chiasm is located 
within the center of suprasellar cistern. On lateral aspect, pair of cavernous sinuses exist 
which contain internal carotid artery along with oculomotor, trochlear and abducent nerves 
in addition to the first and second divisions of trigeminal nerve (6, 7). 
The pituitary gland occupies the sella turcica and consists of two parts called as anterior 
(adenohypophysis) and posterior (neurohypophysis) pituitary. These lobes are 
developmentally and functionally different. Anterior pituitary is formed from the 
evagination of oral ectodermal tissue called Rathke’s pouch, which is derived from the 
nasopharyngeal tissue during the embryonic period. Posterior pituitary is derived from 
diencephalic neuroectoderm and is connected to the hypothalamus via pituitary stalk. 
Antidiuretic hormone and vasopressin are formed in the hypothalamus and travel to the 
posterior pituitary and are stored there. The pars intermedia is located between the anterior 
and posterior pituitary and is regarded as vestigial (6-8).   
Anterior pituitary constitutes the 75% of entire pituitary volume and occupies the anterior 
portion of sella turcica.  Posterior pituitary occupies the central portion of sella turcica and is 
surrounded on both sides by two wings of anterior lobe. MRI easily distinguishes both 
anterior and posterior pituitary lobe. Posterior pituitary often manifests as markedly 
hyperintense on T1 weighted images and moderately hyperintense on T2 weighted imaging 
due to the presence of arginine-vasopressin in neurohypophysis. Entire pituitary gland 
shows contrast enhancement (figure 1) on both CT and MRI (6-8).  
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Normal precontrast sagittal(1c), coronal (1d), post contrast sagittal (1e) and coronal (1f) MRI of pituitary 
stalk and pituitary gland 
Fig. 1. Normal CT sagittal post contrast soft tissue window (1a) and bone algorithm (1b) 
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The hypothalamus is the ventral part of diencephalon and extends from lamina terminalis to 
a vertical plane posterior to the mamillary bodies and from hypothalamic sulcus to the pial 
surface of the floor of the third ventricle (5-6).  
Posterior lobe of the pituitary has rich and direct blood supply which explains extensive 
immediate contrast enhancement of posterior lobe. Anterior pituitary is supplied by the 
portal pituitary system which explains delay in contrast accumulation in anterior pituitary 
lobe compared to the posterior pituitary lobe. Similarly, due to relatively deficient vascular 
supply of anterior lobe, it is more vulnerable to ischemic insults such as Sheehan’s 
syndrome and pituitary apoplexy (6). 
Dimensions and shape of pituitary are variable during different physiological states. At 
birth, pituitary is usually globular in shape and reveals hyperintensity on T1 weighted 
images in both anterior and posterior lobe. At about 6 weeks of postnatal life, anterior lobe 
loses hyperintensity and become isointense to that of cerebral white matter. On the other 
hand, posterior pituitary retains its hyperintensity which serves as an important landmark 
throughout the life. Pituitary is usually larger in size in female and further increases during 
pregnancy. Also at adolescent, pituitary size increases physiologically. Despite variations in 
size, shape and height, pituitary gland should fill the whole sella turcica with variations in 
height (6-8).  
5. Role of imaging 
MR imaging is the modality of choice for evaluating central diabetes insipidus due to its 
multiplanar imaging capability, better tissue contrast resolution and capability to selectively 
suppress individual tissue signal like fat. CT scan is better than MRI for detecting 
calcifications, bone destruction and osteolytic lesions (6-8). 
5.1 MR imaging protocol 
Coronal T1, coronal  T2, small field of view sagittal T1 weighted images of the sella with and 
without fat saturation are obtained.,  After injection of the intravenous contrast, fat 
suppressed sagittal and coronal T1 weighted images of the sella are also obtained. MRI of 
the brain with and without contrast is also performed for a comprehensive evaluation of the 
pituitary, sellar and parasellar region (6).  
Nephrogenic diabetes insipidus is characterized by a decrease in the ability to concentrate 
urine due to resistance to ADH action in the kidney. Diagnosis of NDI is often clinical and 
laboratory based and imaging has marginal benefit in this group of DI (1, 4, 5). 
6. Central Diabetes Insipidus (CDI) 
6.1 Idiopathic Central Diabetes Insipidus 
It is the most common type of diabetes insipidus (DI) and is seen in 30-50 % of patients 
diagnosed with CDI. It has been suggested that idiopathic CDI is an autoimmune disease 
characterized by the lymphocytic infiltration of posterior pituitary and pituitary stalk. The 
role of autoimmunity is evident from the association of this disease with other autoimmune 
conditions and presence of cytoplasmic antibodies against the vasopressin. On MRI, 
posterior pituitary and pituitary stalk often appear thickened and enlarged, particularly 
during the early stage. Such presentation is more common in young female patients. 
However, thickening of pituitary is a non specific finding since patient having such 
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presentation on the MRI, may develop germinoma or histiocytosis. Particularly, progressive 
thickening of pituitary stalk in pediatric patients on serial MRIs is often due to germinoma. 
In addition, other endocrine abnormalities are also seen in such patients including 
suppressed release of growth hormone (GH), thyroid stimulating hormone (TSH) and 
adrenocorticotropic hormone (ACTH) (3).  
6.2 Familial Central Diabetes Insipidus 
Familial CDI or familial neurohypophyseal diabetes insipidus (FNDI) is often an autosomal 
dominant disease which is caused by mutations in the arginine-vasopressin gene (AVP). 
This mutation leads to accumulation of misfolded arginine-vasopressin fibrillar aggregates 
within the endoplasmic reticulum and causes death of the magnocellular neurons of SOP 
and PVN nuclei of hypothalamus. This phenomenon is called toxic gain of function and is 
also seen in other neurodegerative conditions such as Huntington disease and Parkinson 
disease. However, it is unclear how these aggregates cause death of magnocellular neurons. 
Children born with autosomal dominant disease often develop symptoms several months or 
years following the birth (9). 
6.3 Structural causes 
6.3.1 Congenital 
Septo-optic Dysplasia: 
Septo-optic Dysplasia (figure 2) is a disease spectrum with variable combination of the 
following components: 
• Optic nerve hypoplasia 
• Pituitary abnormality such as ectopic posterior pituitary 
• Absent septum pellucidum 
Septo-optic dysplasia is associated with abnormalities of cortical development and 
hypothalamic-pituitary dysfunction. Suppression of hypothalamic-pituitary axis leads to 
growth retardation secondary to suppressed release of growth hormone and TSH from the 
anterior pituitary. In addition, such involvement also affect serum level of ADH since ADH 
is released from the hypothalamus and stored in posterior pituitary before release into the 
circulation causing CDI. In addition, these children exhibit variable combinations of cleft 
palate, syndactyly, ear deformities, hypertelorism, optic atrophy, micropenis, and anosmia 
(10).  
Affected children have mutations in the HESX1 gene, which is involved in early 
development of the ventral prosencephalon. Pituitary dysfunction leads to diabetes 
insipidus, GH deficiency and short stature, and, occasionally, TSH deficiency (11). 
Posterior pituitary stores hormones released from the hypothalamic neurons which reach 
posterior pituitary via descending axons. These axons are covered by the ascending 
ectodermal cells of the Rathke’s pouch as they migrate towards the posterior pituitary 
during development. The development of posterior pituitary is complete by the end of first 
trimester. Abnormality of the migration can lead to ectopic posterior pituitary gland located 
either near the median eminence or along the pituitary stalk (12).  
Tuber Cinereum Hamartoma 
Tuber Cinerium Hamartoma is a congenital disorder of defective neuronal migration 
characterized by gray matter heterotopias, formation of which typically begins during the  
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(c) 
Fig. 2. MRI of Septo-Optic Dysplasia: Axial T2 (2a) shows bilateral optic nerve hypoplasia, 
right retinal detachment and right microophthalmia from retinopathy of prematurity. 
Coronal T1 (2b) shows absent septum pellucidum. Sagittal T1(2C) shows ectopic posterior 
pituitary bright spot.  
days 33-41 of gestational life. It is approximately 1-3 cm in size, nonneoplastic and 
disorganized collection of hypothalamic neurons, glia and fiber bundles. It is typically 
located on the floor of third ventricle within the tuber cinereum of the hypothalamus. 
Recent literature suggested that tuber cinereum hamartoma accounts for about 33% of all 
cases of true precocious puberty and is seen more commonly in boys than girls. The 
precocious puberty seen in these patients develops about 2 years earlier than in idiopathic 
precocious puberty and patients are often less than 3 years of age (13-14).  
The induction of precocious puberty is due to pulsatile release of GnRH from the 
hamartoma which leads to premature activation of hypothalamic-pituitary-gonadal axis. 
Occasionally patients present with acromegaly secondary to excessive growth hormone 
release from the Hamartoma. In addition to hormonal disturbances, patient often present 
with gelastic epilepsy (spasmodic or hysterical laughter) with interval irritability and 
depressed mood. In addition, several other malformations are also noted in association with 
tuber cinereum Hamartoma such as polydactyly, microgyria, hemispheric heterotopias, 
corpus callosum agenesis, mental retardation and behavioral problems. Occasionally, tuber 
cinereum hemartomas can be a part of Pallister-Hall syndrome which is caused because of a 
frameshift mutation of chromosome 7p13 and is characterized by multiple malformations, 
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such as polydactyly and imperforate anus. However, neurologic symptoms are less severe 
in patients with Pallister-Hall syndrome (13-14).  
With smaller (3-15 mm) pedunculated mass, patient is often asymptomatic or may only have 
central precocious puberty. However, with large (10-38 mm) and sessile lesions, patient 
often display multiple symptoms including seizures. Radiography in patients with tuber 
cinereum hamartoma and precocious puberty show advanced bone age, evidence of 
intracranial calcification, increased intracranial pressure and enlarged sella turcica. In 
addition, ultrasonography shows enlargement of ovaries accompanied by several small 
cysts/follicles, prominence/enlargement of uterus and well defined central endometrial 
lining.  CT has limited role due to decreased sensitivity at the level of sella turcica and 
shows isodense mass compared to the gray matter without any evidence of calcification and 
contrast enhancement. Therefore, MRI is the main modality for identifying hypothalamic 
hamartoma (figure 3) which shows isodense lesion to gray matter on T1 weighted images 
which do not enhance with contrast along with preservation of pituitary bright spot. On T2 
weighted images Hamartoma is either isointense or slightly hyperintense compared to gray 
matter. Particularly, lack of enhancement helps to differentiate hypothalamic Hamartoma 
from germ cell tumor, Langerhans cell histiocytosis and hypothalamic glioma which are also 
seen in the same location and show at least partial uptake of contrast (13-14).  
Recently, it has been reported that MR spectroscopy can also play an important role in 
diagnosis of tuber cinereum hamartoma with more information regarding the functional 
status of this mass. Since the mass is slow growing and rarely cause mass effect, initial 
treatment is symptomatic management and includes hormone suppressive therapy with 
leutenizing hormone antagonist such as leuprolide or continuous administration of GnRH 
analogs which effectively suppresses premature precocious puberty and seizures. Surgery is 
reserved for those patients having intractable seizures or rapid growth of mass with no 












Fig. 3. Hypothalamic Hamartoma. Precontrast coronal (3a) and sagittal (3b) images show 
isointense lesion in the region of hypothalamus. Post contrast image (3c) show lack of 
enhancement of the lesion. 
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6.3.2 Traumatic 
Iatrogenic injury from neurosurgical procedures especially after trans-sphenoidal surgery 
can lead to the CDI because of iatrogenic damage to the hypothalamus and posterior 
pituitary. For example, transsphenoidal removal of small tumors limited to sella has 
resulted in development of CDI. Whereas, removal of large tumors has been shown to 
precipitate CDI in as high as 60-80% of total patients. The incidence rate declines 
significantly in patients who have undergone minimally invasive endoscopic pituitary 
surgery (2.7% permanent and 13.6% transient). The likelihood of developing permanent CDI 
is higher if plasma sodium level reaches level higher than 145 mmol/L within the first five 
days postoperatively.   
Occasionally, neurosurgery or head trauma causes severe damage to the hypothalamus and 
pituitary stalk. In such scenarios, often triphasic response is seen. In the beginning, polyuric 
phase is present which lasts up to 4-5 days and is due to inhibition of ADH release from the 
hypothalamus.  This is followed by antidiuretic phase between days 6-11 that is 
characterized by the slow release of ADH from the posterior pituitary and leads to 
hyponatremia secondary to antidiuretic effects of ADH. Once the ADH store in posterior 
pituitary is depleted, patient develops permanent CDI. However, it is important to note that 
very often the damage to hypothalamic-pituitary axis is mild to moderate and does not 
cause permanent CDI. 3.4% of patients had transient polyuria and then transient 
hyponatremia. It is very important to realize that polyuria seen following a major surgery 
including neurosurgery is not always due to CDI and may result from excess IV fluids given 
during the surgery, and also from osmotic dieresis induced from administration of mannitol 
and glucocorticoid for minimizing the cerebral edema. These conditions can be 
differentiated from CDI by measuring urine osmolality and the response to water restriction 
and the administration of ADH. Usually, urine osmolality is less than plasma osmolality 
and less than 300 mOsm/kg and plasma AVP concentration is low in spite of high plasma 
osmolality in the CDI Rarely, patient develops combination of CDI and cerebral salt wasting 
following neurosurgery (15).  
6.3.3 Inflammatory 
Tuberculous meningitis 
Tuberculous meningitis is aseptic meningitis which is often caused because of the spread of 
infection from the pulmonary focus via hematogeneous route but can also occur because of 
contiguous spread from adjacent focus of infection. The most common endocrinal 
disturbance noted is hyperprolactinemia followed by cortisol deficiency and central 
hypothyroidism. In addition, isolated cases of SIADH and CDI have also been reported.  
Intracranial tuberculosis presents as sellar or suprasellar tuberculoma along with 
calcification, obstructive hydrocephalus, vasculitis or apoplexy. Characteristic MRI changes 
include sellar tuberculoma, osteomyelitis of adjacent bones, caseous necrosis, dural 
enhancement and exudates in and around the pituitary gland in addition to thickened 
pituitary stalk. Post contrast studies show nodularity or thickening of the stalk and 
infundibulum. The pituitary tuberculomas are heterogeneously isointense on T1 weighted 
imaging and hyperintense on T2 weighted imaging with intense enhancement with contrast. 
Occasionally, T1 weighted images show hyperintensity attributed to the high protein 
content and the non-enhancing areas are likely due to caseous necrosis (16). 
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Sarcoidosis 
Sarcoidosis is a chronic noncaseating granulomatous disease characterized by abnormal 
collection of chronic inflammatory cells including lymphocytes, macrophages and 
multinucleated giant cells at various locations including lungs, lymph node, skin and neural 
tissue. It is more common in African American female. Disease course is often insidious and 
patient may remain asymptomatic. Occasional spontaneous remissions and improvements 
have been reported but relapse rate of more than 50% is also seen.  About 10% patients 
develop serious morbidity due to pulmonary scarring and respiratory failure.  However, 
other nonspecific symptoms include fatigue, difficulty to sleep, lack of energy and 
motivation, joint swelling and pain, blurry vision, skin rash, shortness of breath. Skin lesions 
include rash, erythema nodosum (swelling in front of anterior tibia or shin) and lupus 
pernio. There are some variants of sarcoidosis. For example, triad of erythema nodosum, 
bilateral hilar lymphadenopathy and arthalgia is called Lofgren syndrome that has good 
prognosis compared to other variants. Involvement of CNS is referred as neurosarcoidosis 
and is noted in 5% of patients diagnosed with sarcoidosis. In addition, about 33% of patients 
diagnosed with neurosarcoidosis develop some degree of CDI. In addition, occasional 
hypothalamic disturbances and defects in anterior pituitary hormonal release are also noted 
in such patients. Neurosarcoidosis affects leptomeninges, vascular structures, cranial nerves, 
hypothalamus, infundibular stalk and pituitary gland. DI is suggested to be due to the either 
vasculitis or direct granulomatous effect.  
As with other inflammatory condition involving pituitary stalk, MRI shows uniformly 
thickened pituitary stalk but occasional involvement of adjacent hypothalamus and 
pituitary is seen. Similar to other granulomatous disease, strong contrast enhancement is 
also seen. Interestingly, such features on MRI are seen only in patients who have CDI for 
less than 2 years and are lost upon follow up suggesting that neurosarcoidosis induced DI is 
self limiting (17-18).  
Wegener's granulomatosis 
Wegener s granulomatosis (WG) is a systemic, necrotizing, granulomatous vasculitis of 
small and medium sized vessels that was first described in detail by Friedrich Wegener in 
1939. It is a chronic disease of unknown etiology and is closely associated with elevated 
serum levels of anti-neutrophil cytoplasmic antibody (ANCA). Once diagnosis is 
established, WG require lifelong immunosuppresion because of propensity to cause 
irreversible end organ damage.  It affects multiple organ systems, such as upper and lower 
airway involvement (sinusitis, epistaxis, dyspnea and cough), kidney (impaired kidney 
functioning, rapidly progressive glomerulonephritis and chronic kidney failure) and other 
organs. In about one third of patients, CNS is involved and patient exhibit features of 
peripheral neuropathy, mononeuritis multiplex, cranial nerve palsies, stroke, cerebral 
vasculitis and rarely CDI. Involvement of posterior pituitary in WG is very rare with only 
less than 50 cases described in literature so far since 1953. Due to rare association between 
WG and CDI, it is often missed during the early course of disease. Therefore, it is very 
important for physicians to suspect WG in any patient presenting with nasal congestion, 
epistaxis, dyspnea, polydipsia and polyuria.  Definitive diagnosis is established by tissue 
biopsy that often shows leukocytoclastic vasculitis with granulomatous inflammation.  
On MRI, WG-induced CDI appear as diffusely enlarged pituitary and infundibular stalk 
compared to optic chiasm and occasionally intrasellar mass is seen. In addition in some 
patients, cystic changes have been reported in pituitary and infundibulum but no contrast 
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enhancement is seen. Loss of posterior pituitary bright spot is seen on T1 weighted images 
(likely due to significant decrease in arginine-vasopressin content in posterior pituitary) and 
no contrast enhancement is noted.  Occasionally, MRI failed to show any changes in 
pituitary in patients with proven clinical CDI and WG. In such patients, it has been 
suggested that CDI is caused because of small vessel vasculitis and therefore remain 
undetected. Treatment is often directed at immune suppression (19-20). 
Lymphocytic infundibuloneurohypophysitis and lymphocytic adenohypophysitis 
Lymphocytic Infundibuloneurohypophysitis and Lymphocytic Adenohypophysitis were 
initially identified as one of the most important causes of idiopathic DI. Lymphocytic 
Adenohypophysitis is a rare autoimmune disease which is seen more commonly in younger 
female of menstrual age and is acute in onset. Patients often have other autoimmune disease 
as well and are positive for autoantibodies against arginine-vasopressin secreting cells. It is 
not yet clear whether these antibodies are cytotoxic and cause DI via damaging the neural 
tissue. However, their presence indicates the high likelihood of development of overt DI in 
such patients. Such patients have long history of subclinical disease followed by clinically 
obvious DI.  
MRI in lymphocytic adenohypophysitis typically shows pituitary infundibulum thickening 
and neurohypophysis enlargement in such patients. During the early subclinical phase, 
posterior lobe of pituitary is often hyperintense on MRI but become normal again indicating 
the self-limiting nature of this disease. Upon biopsy, inflammatory infiltrate consisting of T 
lymphocytes and plasma cells is identified in the affected tissues with occasional presence of 
macrophages, neutrophils and eosinophils in the anterior pituitary. Interestingly, treatment 
with DDAVP leads to recovery of posterior pituitary function along with disappearance of 
autoantibodies.  
Lymphocytic Infundibuloneurohypophysitis presents with the combination of CDI and 
vision disturbances and might have serum positivity for autoantibodies against arginine-
vasopressin secreting cells. Lymphoplasmacytic infiltrate is seen in hypothalamus, pituitary, 
infundibulum, optic nerve, tract and chiasm. MRI imaging in these patients show normal 
pituitary with focal nodular thickening of the infundibulum, stalk thickening, and absence 
of hyperintense signal of neurohypophysis. Occasionally, anterior pituitary is also affected. 
Overall, it is also a self-limiting disorder and no treatment is needed except hormone 
replacement for short duration of time. In addition, glucocorticoid therapy is also given to 
decrease the intracranial pressure (21-22).  
6.3.4 Neoplastic 
6.3.4.1 Pediatric neoplastic causes 
Hypothalamic glioma 
Hypothalamic gliomas are low-grade tumors arising from glial cells and are classified as 
World Health Organization grade I tumors. Despite low grade, these tumors are associated 
with higher morbidity and mortality. Very often these tumors are located in optic 
chiasmatic/hypothalamic region but are also seen in the posterior fossa, temporal lobe and 
spinal cord. Hypothalamic gliomas are commonly seen in childhood and adolescent age 
group. However, hypothalamic gliomas are occasionally seen in adults and are more 
aggressive than their pediatric counterparts. Male and female are equally affected.  
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About one third of the hypothalamic gliomas are associated with neurofibromatosis 1, 
which is an autosomal dominant disease resulting from mutation on chromosome 17. 
Patients who have associated NF1 have been reported to have better prognosis than those 
without NF1 and are characterized by smaller, often non-cystic lesions with more frequent 
involvement of the orbital portion of optic nerve. On the other hand, gliomas without 
associated NF1 are larger, cystic and frequently affect hypothalamus and optic chiasm. In 
severe cases, calcification is noted within the stroma of hypothalamic glioma, making it hard 
to distinguish from craniopharyngioma. Clinical presentation includes headache, visual 
disturbances, failure to thrive, hyperactivity and endocrinal disturbances such as diabetes 
insipidus.  
On CT scans, hypothalamic gliomas are hypodense compared to the gray matter whereas on 
MRI, the mass (figure 4) is hypointense to isointense on T1 weighted images and 
hyperintensive on T2 weighted images. The contrast enhancement is variable but usually 
mildly homogeneous. Large gliomas may have cystic component that is hypodense on CT 
and hyperintense on T2 weighted MRI. T2 weighted images are useful for delineating the 
spread of tumor along the optic tract. Angiography is performed in case of giant and rapidly 
growing tumors with signs of malignant transformation identifying cerebral vessel 
displacement and enhancement of abnormal vascular tumor net. Treatment is based on the 
aggressiveness of the tumor and often involves the combination of surgery, chemotherapy 
and radiotherapy (23-24).  
Craniopharyngioma 
Craniopharyngioma (CPH) is a benign tumor, which derives from Rathke’s pouch. It is 
postulated to arise from cells of the embryonic epithelium lining the pharyngeal-pituitary 
passage extending from the bottom of third ventricle up to the wall of pharynx. It 
constitutes 10% of all pediatric brain tumors, 90% of all pituitary masses and 56% of all 
chiasmal-sellar tumors. Two varieties have been identified including cystic (or 
adamantinomatous) tumors (ACPs) and squamous-papillary variety that are markedly 
different both clinically and pathologically.  
ACP is more commonly seen and is often noted in pediatric patients (between 5-10 years of 
age). It is characterized by one or more large cysts with variable wall thickness and central 
proteinacious fluid that has machine oil consistency. In addition, it also has variable 
proportion of solid component. Overall, it is an inhomogeneous mass commonly associated 
with both solid and cystic component and some degree of calcification in more than 90% of 
cases. It is commonly seen in sellar and suprasellar location.  
Squamous papillary variant is often solid in nature and rarely present with cystic 
component. Calcification is not commonly seen. They are often large masses and lead to 
mass effect and location specific manifestations. Patient often develop Horner syndrome, 
neurological deficit, epilepsy, headache, pseudotumor cerebri and elevation in intracranial 
pressure. 
It is associated with CDI both before and after the curative surgery with higher incidence 
noted postoperatively. Interestingly, patients who underwent transfrontal removal of 
craniopharyngioma have no biologically active ADH in the serum despite elevated level of 
immunoreactive ADH. In addition, replenishment of ADH level is not effective. This 
presentation mimics nephrogenic DI. However, CDI in this setting is often transient. 
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Fig. 4. Hypothalamic Glioma: Precontrast sagittal T1 (a), axial T1 (b), post contrast axial T1 
(c) and coronal T1 (d) images of pilocytic astrocytoma involving hypothalamus 
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Imaging is very important for identifying CPH, and for delineating the location and extent 
of craniopharyngioma (figure 5). For example, plain radiography reveals changes in shape 
and size of the sella turcica, deformity of the anterior clinoid process along with 
calcifications in the chiasmal–sellar region. In addition, calcification is often seen within the 
cavity of sella and often present as laminar pattern of calcification within the capsule. In 
majority of the patients with CPH, the dorsum sella turcica is shortened. Mass effect on the 
third ventricle causes increase in intra-ventricular pressure with dilatation of ventricular 
system and widening of bony sutures. CT and MRI provide more detailed and accurate 
description of CPH, including precise size of the tumor, proportion of solid and cystic 





Fig. 5. Sagittal T1W post contrast MR image shows a complex solid and cystic  sella-supra 
sellar enhancing mass. This was a proven Craniopharyngioma on histopathology. 
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On CT, it appears as a well defined mass with heterogeneous density. Solid part is isodense 
to the brain but cystic part is usually hypodense than that of brain. Density of solid 
component increases considerably upon contrast enhancement. CT may show hypodense 
lesion within the ventricles with peripheral rim of calcification. T1 weighted MR images of 
cystic component are often heterogeneous ranging from hypointense to hyperintense signal 
depending on the protein content of cyst whereas the solid or nodular part of tumor is 
usually isointense. On T2 weighted images, cystic area appears hyperintense with 
hypointense foci representing calcification. Proteinacious nature of the cystic fluid causes 
hyperintense signal on T1weighted images and mild hyperintensity on T2-weighted 
imaging at the periphery. On sagittal images, sedimentation phenomenon of cystic content 
can be seen. On MRI, intense contrast enhancement is seen in the wall of the cyst and also in 
the solid component of the tumor (25-26).  
Intracranial germ cell tumors 
Intracranial germ cell tumors often located close to the midline and could be both benign 
and malignant.  Germ cell tumors arise due to defective migration of primordial germ cells 
and are commonly seen within the gonads, mediastinum or in the pineal region. In fact 
more than 50% of tumors within the pineal regional are germ cell tumors. It usually presents 
between the age of 10-12 years and males are more frequently affected if tumor is located 
within the pineal regions whereas slight female preponderance is noted in case of 
suprasellar germ cell tumors. Most of the intracranial germ cell tumors are within the pineal 
region and 20% are seen in suprasellar region and few are identified in the pituitary fossa. 
AFP and b-HCG levels are elevated in patients with germ cell tumor and are routinely used 
for screening purpose and monitoring response to treatment. They constitute 3-5% of 
pediatric intracranial tumors and 0.5-1% of adult intracranial tumors. Common clinical 
features are endocrinal disturbances such CDI, precocious puberty and panhypopituitarism. 
In addition, obstructive hydrocephalus, visual defects and optic nerve atrophy are also seen.  
On CT, germ cell tumors (figure 6) appear as hyperdense lesions with homogeneous contrast 
enhancement. It often shows abnormal subtle pituitary stalk thickening and enhancement in 
patients with CDI. On MRI, germinoma are isointense or mildly hypointense on T1 weighted 
images and isointense or mildly hyperintense on T2 weighted images. Strong contrast 
enhancement is seen on both CT and MRI. Treatment of choice is radiotherapy with excellent 
prognosis. Chemotherapy is used in radiotherapy resistant tumors (27-28). 
Teratoma 
Teratomas are usually benign tumors which contain elements derived from all the three 
germ layers and are covered by a capsule. They are commonly seen in pediatric male 
patients. When located intracranially, these lesions have predilection for the midline and 
involve the pineal region, the third ventricle, and the infundibulochiasmal region. Rarely, 
intracranial suprasellar teratomas extend into the pituitary fossa, with enlargement of the 
sella turcica, thereby resulting in visual disturbance, DI, and hypopituitarism.  
Sella is often enlarged with widening of the entry and depression of the bottom. Often teeth 
like inclusions are seen with in the sella and around it. Occasionally, initial MRI may fail to 
identify the mass. However, upon follow up with T1- and T2-weighted MR imaging, high 
signal intensities representing fat components can be seen in sellar and suprasellar areas. 
Very often, MRI reveals teratomas as heterogeneous mass secondary to the presence of all 
three germ line structures which enhance following contrast administration (29-30).  
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Fig. 6. Hypothalamic Dermoid: Non-fat suppressed coronal T1 (a) and sagittal T1 (b,c) 
shows hyperintense T1 signal in the hypothalamic mass that suppresses on fat suppressed 
T1 sagittal (d ) image representing fat in the dermoid. 
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Langerhans cells histiocytosis 
Langerhans Cells Histiocytosis refers to the group of granulomatous disease characterized 
by abnormal activation and clonal proliferation of immune cells called histiocytes or 
Langerhans cells and is mostly seen in children between 1-4 years of age. These cells are 
bone marrow derived and are a variant of dendritic cells that normally reside in the skin. 
Upon entry of foreign antigen into body via breach of skin, these cells engulf and process 
these antigens and migrate to the nearby lymph node. They present these antigens to the 
macrophages and other immune cells and activate the cascades of both cellular and humoral 
immune response against the foreign antigen. However, upon abnormal activations, these 
cells can lead to the granumatous disease causing erosive and painful bone lesion in 
addition to effect on multiple other organ systems.  
There are three variants of histiocytosis including malignant (true histiocytic lymphomas), 
reactive (benign histiocytosis) and Langerhans cell histiocytosis (LCH). Depending upon the 
nature of bone involvement, LCH is further classified into three variants including unifocal, 
multifocal unisystem, and multifocal multisystem. In all these variants, LCH provokes 
nonspecific immune response and leads to painful bone swelling, erosive bone lesion and 
pathologic fractures, hepatosplenomegaly, lymphadenopathy, pancytopenia, infection, 
fever, skin rash, hormonal disturbances including diabetes insipidus, chronic cough, 
shortness of breath and granulomatous lung disease. LCH is commonly seen in pediatric 
patients and twice common in boys than girls.  
Frontal bone is most commonly involved however any bone can be affected and develops 
punched out lesions with sharp margins and no sclerosis. Particularly, chronic recurrent form 
is referred as Hand-Schuller-Christian disease which presents as a triad of Diabetes insipidus, 
proptosis and destructive bone lesions. On the other hand, acute form of disease is called as 
letterer-siwe disease which presents with hepatomegaly, splenomegaly, fever, eruptive skin 
lesion, thrombocytopenia and anemia. Diagnosis is established via biopsy and 
immunohistochemistry with positive reactivity for CD1a and S-100 proteins. In addition, 
electron microscopy shows abnormal membranous aggregates of endoplasmic reticulum in 
tennis racket shaped or rod shaped structures called birbeck granules or birbeck bodies (200-
400 nm in width). These bodies characteristically show central linear density and a striated 
appearance and are regarded as pathognomic of histiocytosis. It is reported that formation of 
these bodies is induced by Langerin (CD207), which is transmembrane II surface receptor 
present on the membrane of Langerhans cells. Clinically, several hormonal disturbances are 
seen but the most common is diabetes insipidus followed by growth retardation. In addition, 
galactorrhea, hypogonadism and hypopituitarism are also occasionally seen secondary to 
histiocytic infiltration of hypothalamus and partial or complete inhibition of the release of 
hypothalamic trophic hormones which subsequently suppresses pituitary hormonal release.   
On radiographs, variable sized lytic foci are seen with characteristic beveled edge 
appearance of lesion margin. Occasionally, focal residual bone lesion with button 
sequestrum is also seen lying centrally within the area of lytic lesion. On CT scan, button 
sequestrum lesions are seen as sharply defined hypodense intradiploic bony defects. In 
addition, lytic foci and erosive changes are also seen on CT scans. On MRI, button 
sequestrum lesion appears as low to intermediate intensity lesion on T1 weighted images 
and hyperintensity lesion on T2 weighted images. In addition, contrast enhancement with 
fat suppression enhances the diagnostic yield and helps identify the extent of lesion, 
invasion of adjacent epidural space, brain parenchyma or dural venous sinuses. In addition, 
scintigraphy is also helpful but show variable isotope uptake, such as smaller lesions show 
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enhanced uptake and less or no uptake in bigger lesions. This modality help identify 
multiple osseous and tissue lesions and is of use for narrowing the differential diagnosis. 





Fig. 7. Histiocytosis involving the pituitary infundibulum. Sagittal non contrast T1W MR 
image (top) shows absent posterior pituitary bright spot with thickened enhancing pituitary 
infundibulum on post contrast T1W sagittal MR image (bottom). 
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6.3.4.2 Adult neoplastic causes 
Metastasis 
Metastases to the pituitary-hypothalamic axis account for less than 1% of all the sellar 
masses. Breast cancer metastases are most common, accounting for 6-8% of all the metastasis 
to the pituitary followed by lung and GI cancers. When cancers metastasize to pituitary, 
most cancers involve the neurohypophysis but breast cancer demonstrates high affinity for 
the adenohypophysis. DI is the most common presenting symptoms in such patients and is 
seen in about 20% of such patients. Other manifestations include vision problems, anterior 
pituitary dysfunction, headache and ophthalmoplegia. It is permanent if SOP and PVN 
nuclei of hypothalamus are involved. If SON and PVN nuclei are spared and only posterior 
lobe of the pituitary is involved, than CDI is often transient.   
MRI is very useful for diagnosis and shows a destructive and inhomogeneously enhancing 
lesion extending across intrasellar and suprasellar location. In addition, diffuse enlargement 
of the gland, thickening of the pituitary stalk, invasion of the cavernous sinus, and sclerosis 
of the surrounding sella turcica can also be noted. If metastasis is localized to the skull base, 
sclerosis of sella turcica is more obvious. On the other hand, if metastasis is located within 
the pituitary parenchyma, sella turcica sclerosis is minimal (33).  
7. Psychogenic Diabetes Insipidus 
It is caused by compulsive intake of large amounts of fluid leading to inhibition of normal 
vasopressin. Obviously, there are no imaging features of this entity. Exclusion of any 
intracranial lesion by MRI of brain and sella with and without contrast might aid in its 
diagnosis (2). 
8. Nephrogenic Diabetes Insipidus (NDI) 
a. Primary: It is X-linked recessive condition with unresponsiveness of the tubules and 
collecting system to vasopressin. For obvious reasons there are no specific imaging 
features of this entity.  
b. Secondary: Polycystic kidney disease, drug toxicity such as Lithium toxicity, analgesic 
nephropathy, reflux nephropathy, amyloidosis, acute tubular nephropathy.  
Polycystic kidney disease 
Polycystic kidney disease (also known as PKD) is the most common life threatening genetic 
disorder of kidney can be either autosomal recessive (AR) or autosomal dominant (AD). 
Both ADPKD/ARPKD are characterized by the development of multiple cysts in both the 
kidneys, which are often fluid filled leading to increase in size of kidneys.  
ADPKD is the most common inherited kidney disease and is postulated to have begun 
during the embryonic life with fewer than 5% of nephrons being affected at the time of birth. 
Because of fluid accumulations, cysts continue to grow and cause pressure atrophy of renal 
parenchyma and worsening of renal failure.  Increase in serum creatinine is noted during 
the second and third decade of life with obvious renal failure during 6th-7th decade of life. 
Clinical features include abdominal discomfort and pain (most common), hematuria, 
urinary tract infection, high blood pressure, intracranial bleeding, nephrolithiasis, colon 
diverticulosis, hepatic cysts, pancreatic cysts, splenic cysts, cysts in seminal vesicle, cardiac 
cysts, arterial aneurysms (cranial vessels and aorta), abdominal wall hernias, aortic and 
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mitral valve abnormalities, end stage renal disease, kidney failure and occasionally 
nephrogenic diabetes insipidus (34-35).  
Autosomal recessive PKD (ARPKD) is also called infantile PKD since signs of kidney 
involvement are often identified even before the birth of child. Children often die within the 
first few days because of respiratory difficulties arising because of lung hypoplasia secondary 
to oligohydramnios. In addition, with increasing age, liver scarring is also noted in children.  
The diagnosis of PKD is established via imaging (figure 8). Expansile fluid filled cysts of 
various sizes along with distorted renal cortex and medulla in addition to stretching and 
elongation of kidney tubules and blood vessels are often noted. Ultrasound is recommended 
for the initial screening because of ease of performance, easy availability, low cost and no 
risk of radiation. But, the data obtained with ultrasound is often not reproducible and as 
accurate as compared to which is obtained via CT or MRI. Occasionally other complications 
also develop such as infection, hemorrhage, cyst rupture and peritonitis that can also be 
identified on cross sectional CT or MRI. CT is also useful for volume measurement and 
assessing structural defects in kidney, however, it involves the use of contrast and radiation.  
 
 
Fig. 8. Coronal HASTE (left) and axial TRUE-FISP (right) MR images show both kidneys 
completely replaced by cysts appearing as bright rounded structures. Notice non-
visualization of any normal renal parenchyma. The patient incidentally also had Polycystic 
Liver Disease. 
Recently, MRI has gained popularity for determining the kidney volume and estimation of 
disease progression. The data obtained via MRI is often reproducible and accurate in 
addition to excellent tissue contrast, high resolution 3D images and no need of contrast or 
radiation. Excellent visualization of renal cyst is obtained via coronal T2 weighted and axial 
fat saturated T2 weighted imaging showing hyperintense cysts throughout both kidneys. In 
addition, simple and complex cysts are easily differentiated with T1 weighted imaging. 
Contrast MRI enable better visualization of renal parenchyma however, use of gadolinium 
contrast can lead to development of nephrogenic systemic sclerosis in such patients with 
impaired kidney functions. In addition, MRI also evaluates the blood flow to the affected 
kidney, which is an important marker of disease progression. With increase in severity of 
disease, the renal blood flow decreases proportionally. In addition, imaging is also very 
important based on the reports that combined renal volume is a prognostic indicator of 
disease severity. CT and MRI are often used for volume measurement over the short period 
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of time whereas in patients with long interval between consecutive follow up, ultrasound is 
the preferred modality. In addition, other quantitative imaging markers, which are often 
linked with disease progression, are size, number, spatial distribution, individual growth 
rate, and asymmetry of cysts. MRI is very often used for measuring and evaluating these 
markers of disease progression. In addition, family history and genetic testing are also 
important in diagnosing PKD. In addition, specific anatomic areas can also be evaluated 
with MRI. Review of literature suggests that kidneys can weigh as much as  8 kg (normal 
weight is 120-140 gram) secondary to the presence of multiple fluid filled cysts (measuring 
up o 3 cm) and have length up to 40 cm. In one recent study, it was found that volume of 
kidney affected by ADPKD was up to 1000 ml (in normal people, mean volume of kidney is 
150 ml). Overall, MRI is superior to ultrasonography and CT. MRI efficiently detects small 
renal cysts as small as 2 mm that are likely to be missed on CT and ultrasound (US). 
However, MRI is more expensive, less readily available, takes longer time to acquire images 
and is contraindicated in certain population such as those with pacemakers and other 
prosthesis. Some of these limitations should be overcome by technical advancements. In 
addition family history and genetic testing are also used for establishing the diagnosis (34-
35). 
Lithium nephropathy 
Lithium is a well established treatment for affective disorders. It has a narrow therapeutic 
window, ranging from 0.6 - 1.2 mMol/L. Lithium nephrotoxicity can be classified into 
nephrogenic diabetes insipidus, acute toxicity, and chronic renal disease. Nephrogenic 
diabetes insipidus is characterized by polyuria and polydipsia. Mild toxicity can be seen at 
serum lithium levels of 1.5 - 2.5 mMol/L, with moderate toxicity at levels of 2.5 - 3.5 
mMol/L (36).  
Lithium toxicity affects multiple organ systems, and may cause coarse tremors, 
neuromuscular excitability, muscle weakness, sluggishness, nausea, vomiting, diarrhea, and 
seizures. Rhabdomyolysis can also occur. Decreasing renal function, evidenced by 
increasing serum creatinine and decreased creatinine clearance, is seen in chronic lithium 
nephropathy. The only established risk factor is lithium therapy, and an increased duration 
of therapy increases the risk of progression to end-stage renal disease (ESRD). 
Discontinuation of lithium therapy does not ensure against progression to ESRD. Chronic 
lithium nephropathy is a progressive condition, and pathology demonstrates tubular 
atrophy, glomerulosclerosis, interstitial fibrosis, and distal tubular dilatation with microcyst 
formation. A recent study found that tubular microcysts were present in 62.5% of renal 
biopsies performed in patients treated with lithium, involved both the renal cortex  
and medulla, and measured 1-2 mm in diameter. A serum creatinine level of 2.5 mg/dL at 
the time of biopsy was found to be the only significant predictor of progression to ESRD 
(36).  
Renal cystic disease is commonly evaluated with US, computed tomography (CT), and MRI. 
US demonstrates well-circumscribed, anechoic cystic structures with posterior acoustic 
enhancement, and CT shows hypodense cystic structures measuring between -10 and +20 
Houndsfield units (HU). The number and nature of cystic lesions is best characterized by 
MRI, and T2-weighted imaging most accurately assesses the fluid content of lesions. MRI is 
a useful tool to evaluate the renal parenchyma, and when combined with magnetic 
resonance angiography (MRA), can effectively study the renal arteries. T2-weighted images 
demonstrate the microcysts of chronic lithium nephropathy as small hyperintense 1-2 mm 
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round lesions. In a patient with a history of lithium therapy, MR imaging of abundant 
microcysts within the kidneys bilaterally strongly supports the diagnosis of chronic lithium 
nephropathy, and may obviate the need for renal biopsy (36).  
Analgesic nephropathy 
Analgesic nephropathy is defined as damage to one or both kidneys resulting from chronic 
exposure to over the counter pain medications such as acetaminophen and NSAIDs or other 
medications containing phenacetin. It has been suggested that approximately 6 or more pills 
for 3 years significantly increases the risk for analgesic nephropathy. It is seen in 4 per 
100,000 thousand patients and is more common in female above 30 years of age, most of 
whom are self medicating for relief from chronic pain. It is more common in Europe, 
Australia and USA. However, its incidence has declined significant in the past few decades 
owing to decreased consumption of phenacetin containing compounds and public 
awareness (43-44). 
Initial changes include scarring of small blood vessels called capillary sclerosis which in turn 
lead to renal papillary necrosis and subsequently chronic interstitial nephritis. In the 
absence of treatment and avoidance of analgesics, patient develops pyelonephritis, renal 
failure, anemia, high blood pressure, NDI and end stage renal disease. These changes are 
postulated to result from decrease blood flow to the kidney because of vessel sclerosis and 
also because of inhibition of prostaglandin E2 production by NSAIDs, depletion of 
antioxidants and oxidative damage to the kidney.  
Both CT and US can be used for assessing kidney damage because of analgesic nephropathy 
and show bilateral decrease in renal volume combined with either bumpy contours or 
papillary calcifications. However, US has higher sensitivity than CT scan for detecting RPN 
due to analgesic nephropathy (37-38). 
Reflux nephropathy 
Reflux nephropathy (RN) caused because of reflux of urine back into kidneys instead of 
going forward into the bladder and then into urethra. It is caused because of defective valve 
at the site of insertion of ureter into bladder and the condition is vesico-ureteric reflux 
(VUR). Over the period of time, reflux of urine back into kidneys injures the parenchyma 
and causes small and scarred kidneys. Scarring is almost always seen and often develops 
within the first five years of life. In addition, patient also develops hypertension, hematuria, 
proteinuria, chronic renal failure, ESRD and NDI. Recurrent urinary tract infection  in male 
and female children raises the suspicion for RN and warrant further investigations. Initial 
investigations of choice are ultrasonogram, voiding cystourethrography and renal 
scientigraphy or nuclear cystography using Tc 99m dimercaptosuccinic acid (DMSA). 
DMSA scan is now regarded as the most sensitive and specific modality for detecting 
inflammatory changes within the kidney and also for identifying VUR, particulary the 
transient episodes and uses low radiation dose. In recent study it was found that DMSA 
scan was positive in children with negative vesicocysto urethrogram (VCUG), indicating 
higher sensitivity with DMSA scan. Chronic reflux nephropathy in adult can also be 
evaluated with IV excretory urography or nephropyelotomography or CT urography, which 
often reveals calyceal distortion with typical claviform morphology. In addition, dilatation 
of intra-renal urinary tract is also seen. On voiding cystourethrogram, backward flow of 
contrast from opacified bladder into the ureter is seen in patients with VUR. In addition, 
contrast enhanced CT or MRI can also show parenchymal changes such as decrease in renal 
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size and presence of notch of the renal parenchyma surface, parencymal scarring, ureteral 
dilatation and calyceal clubbing. Long standing reduction in renal mass often leads to 
glomerular injury and sclerosis. Contrast-enhanced voiding sonocystography is a newer 
modality and useful alternative. This modality is radiation free and uses microbubble-based 
contrast agents. Recently, it has been proposed that contrast-enhanced voiding 
sonocystographyshould be used for both diagnosis and follow up of patients with VUR 
since several recent studies have shown superiority of Contrast-enhanced voiding 
sonocystography over VCUG and nuclear cystography for detecting VUR. In addition, MR 
urography (MRU) is an excellent modality and provides detailed information regarding the 
anatomy (such as renal contour and caliceal configuration) and functioning of urinary tract. 
It is suggested that in many ways MRU is more useful than DMSA scan.  Recently, 
Lonergan et al. demonstrated that gadolinium-enhanced inversion-recovery MR imaging 
has higher sensitivity for detecting focus of infections within the urinary tract and offer 
greater reproducibility. In addition, MRU provides greater resolution, excellent tissue 
contrast, detailed analysis of tubular function without causing background artifact and 
radiation exposure. However, it is an expensive and time consuming modality and requires 
sedation, which negates its usefulness to some extent (39-41).   
Amyloidosis 
Amyloidosis is a group of heritable or acquired diseases characterized by the deposition of 
abnormal proteinacious material as beta-fibrillar sheets in the extracellular space. It can 
affect almost every organ system either alone or in combination. Primary amyloidosis 
develop secondary to immune disorder such as multiple myeloma where as secondary 
amyloidosis is often due to chronic inflammatory diseases such as rheumatoid arthritis. 
Definitive diagnosis is established with biopsy followed by tissue staining with special dyes. 
The commonly used staining agent is Congo Red Dye which causes apple green bifringence 
under polarized light and thioflavine-T (intense yellow-green fluorescence). In addition, 
imaging can also be crucial for managing patients affected with amyloidosis. Its utility 
however has been limited due to the fact that imaging findings are often nonspecific and 
diverse (42-43). 
Renal involvement in multiple myeloma (MM) and rheumatoid arthritis (RA) leads to small 
and contracted kidneys. CT may show either focal cortical mass with focal calcifications or 
diffuse infiltration in the kidney glomeruli or interstitium.  Variability in kidney size reflect 
the stage of disease. For example, during the acute stage, kidneys may be enlarged with 
smooth contour whereas in chronic phase kidneys are often shrunken with diffuse irregular 
contour, thinned cortex and hard texture (called as amyloid contracted kidneys). In 
addition, diffuse cortical thinning is also noted in chronic phase in addition to focal 
parenchymal nodules. Other findings noted in renal amyloidosis are amorphous 
calcification of renal parenchyma, filling defect in renal pelvis either because of blood clot or 
because of amyloid mass and perinephric mass with calcification. In addition, decreased 
renal perfusion and reduced elimination of contrast can also be seen on urography and/or 
angiography in these patients.   
On ultrasound, renal amyloidosis often meets the criteria for type 1 renal parenchymal 
disease. Increase in echogenecity of renal cortex is noted along with medullary prominence 
which is suggested to be due to the deposition of amyloid, calcium or acute parenchymal 
diseases. In addition, corticomedullary demarcation is often prominent and arcuate vessels 
are obscured (42-43).  
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Recently, it has been suggested that diffusion weighted MRI is also of use in evaluating 
renal amyloidosis in patient with familial Mediterranean fever. In addition, nuclear scan 
performed after administration of gallium show enhanced uptake in affected kidneys and is 
suggestive of disease activity. However, PET/CT failed to show enhanced uptake in case of 
cardiac and renal amyloidosis (42-44). 
Acute tubular necrosis 
Acute tubular necrosis or (ATN) is characterized by the death of tubular cells in kidney. 
Tubular cells constitute kidney tubules, which are key structures for transferring urine to the 
ureter. These cells also perform reabsorbtion of 99% of water filtered into Bowman’s capsule 
and concentrate the urine. Tubular cells possess regenerating capacity and continuously 
replace the old and dying cells. This is very important and allows for complete recovery 
from ATN if precipitating cause is eliminated. ATN often presents with ARF and is the most 
common cause of ARF. There are two varieties of ATN. One is ischemic ATN and another 
one in toxic ATN. Ischemic ATN occurs due to decreased perfusion (renal artery stenosis, 
shock, renal artery emboli) whereas toxic ATN occurs due to exposure to toxins (such as 
analgesics or antibiotics, hemoglobin, myoglobin, Bence Jones proteins of multiple 
myeloma, heavy metals, organic solvents, posion and several others). Since the damage 
occurs to the kidney, it is classified as renal cause of acute renal failure. Urinalysis often 
shows pathognomonic muddy brown epithelial cast in patients with ATN along with 
increased fractional excretion of sodium (>3%).  Histopathology shows tubulorrhexis, which 
is a localized necrosis of the epithelial cells lining the renal tubules. In addition, focal 
rupture or loss of basement membrane is also seen developing skip lesions through the 
tubules. Due to loss of basement membrane, regeneration is often unlikely in ischemic ATN. 
In toxic ATN, basement membrane is often intact and allows complete recovery if 
precipitating cause is removed in timely manner. However, in both types, dead or partially 
viable cells shed into tubular lumen and lead to obstruction and eventual renal failure. 
Ultrasound and renal scintigraphy are useful for evaluation and diagnosis of ATN. US show 
swollen and enlarged pyramids with decreased cortico-medullary differentiation and 
increased resistive index. On the other hand renal scintigraphy shows normal perfusion, 
increased retention and decreased excretion (45-46). 
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